Ulta Beauty's Soft 2025 Earnings Guidance Sets Stage For Outperformance, UBS Says

MT Newswires
03-14
ulta.jpg -Shutterstock
Ulta Beauty's (ULTA) full-year guidance missed Wall Street's estimates, but showed potential for positive earnings revisions in the coming quarters, UBS said in a Friday client note.

The beauty retailer late Thursday said that it expects earnings per share between $22.50 and $22.90 in fiscal 2025, below the consensus that UBS put at $23.51. Net sales are projected between $11.5 billion and $11.6 billion, compared with the consensus on FactSet indicating $11.68 billion as of the end of February.

"The operating environment continues to be dynamic, and as we navigate ongoing consumer uncertainty, we believe it is prudent to take a cautious approach to our guidance for fiscal 2025," Chief Financial Officer Paula Oyibo said during a Thursday earnings call, according to a FactSet transcript. "Additionally, as we shared at our Investor Meeting in October, we are planning fiscal 2025 to be a transition year and our view has not changed."

Ulta expects selling, general and administrative expenses to increase 10% for the year. Bulls view that as conservative, leaving "potential upside risk to EPS estimates," UBS analysts led by Michael Lasser wrote in the note.

The stock was soaring 13% in Friday trade, trimming its year-to-date loss to 18%.

"In the near-term, the (company) has continued to manage (2025) EPS expectations well," Lasser said. "We think Ulta's guidance leaves room for positive estimate revisions over the next few quarters."

Ulta forecasts promotional environment to remain "rational" this year and does not see a significant impact from tariffs compared with peers, UBS said. These factors can support the retailer's profitability.

However, Ulta's guidance still indicates some ongoing pressure for its beauty category this year, UBS said.

For the fiscal fourth quarter, Ulta's EPS rose to $8.46 from $8.08 last year, compared with the FactSet-polled estimate of $7.12. Sales fell 1.9% to $3.49 billion, above the $3.47 billion estimate modeled by analysts.















免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10